Clinical trial
An Open-Label Study to Evaluate the Effect of Every Other Week PROCRIT (Epoetin…
NCT00317902 · Ortho Biotech Products, L.P., Industry · Completed
Key facts
| NCT number | NCT00317902 |
|---|---|
| Title | An Open-Label Study to Evaluate the Effect of Every Other Week PROCRIT (Epoetin Alfa) Dosing (40,000-60,000 Units) On Maintaining Quality of Life and Target Hemoglobin Levels in Anemic HIV-Infected Patients (CHAMPS II) |
| Official title | An Open-Label Study to Evaluate The Effect of Every Other Week PROCRIT (Epoetin Alfa) Dosing (40,000-60,000 Units) On Maintaining Quality of Life and Target Hemoglobin Levels in Anemic HIV-Infected Patients |
| Lead sponsor | Ortho Biotech Products, L.P., Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Anemia, HIV Infections |
| Intervention type | Drug |
| Interventions | Epoetin alfa |
| Enrollment | 292 |
| Start date | Oct 1, 2002 |
| Completion | May 1, 2004 |
| First posted | Apr 25, 2006 |
| Last update posted | May 19, 2011 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: